Tirzepatide — lab test, June 2026
COA COA-2026-20-32K matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
J6LX3FT5Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 60 mg · Lab measured 62.46 mg
104% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 15.6 mg using the measured mass, against 15 mg on the label — 4% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-20-32K |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 31 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by ILS Laboratories on June 11, 2026. Reported purity: 99.52%. Net content: 62.46 mg against 60 mg labeled (104% of label). Batch PUR2T60004. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion